Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-15 4:05 pm Purchase | 13D | AVENUE THERAPEUTICS INC. ATXI | Fortress Biotech Inc. FBIO | 180,425 8.900% | 180,425 (New Position) | View |
| 2024-10-25 10:15 am Purchase | 13G | FORTRESS BIOTECH INC FBIO | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,734,854 9.000% | 2,734,854 (New Position) | View |
| 2024-10-01 4:15 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 4,435,534 9.800% | 146,341 (+3.41%) | View |
| 2024-09-25 4:45 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | ROSENWALD LINDSAY A MD | 5,224,779 18.400% | 2,410,874 (+85.68%) | View |
| 2024-06-28 4:26 pm Purchase | 13D | MUSTANG BIO INC. MBIO | Fortress Biotech Inc. FBIO | 2,519,657 7.400% | 2,519,657 (New Position) | View |
| 2024-05-17 5:13 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 4,289,193 11.200% | 1,492,915 (+53.39%) | View |
| 2024-04-17 4:05 pm Purchase | 13D | AVENUE THERAPEUTICS INC. ATXI | Fortress Biotech Inc. FBIO | 3,564,059 8.000% | 2,515,003 (+239.74%) | View |
| 2024-03-22 6:24 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,796,278 7.500% | 352,039 (+14.40%) | View |
| 2024-02-14 4:51 pm Sale | 13G | FORTRESS BIOTECH INC FBIO | Nantahala Capital Management LLC | 372,562 4.200% | -7,595,494 (-95.32%) | View |
| 2024-01-03 4:41 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | ROSENWALD LINDSAY A MD | 2,813,905 15.300% | 216,465 (+8.33%) | View |
| 2023-11-21 4:09 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | WEISS MICHAEL S | 1,130,520 7.600% | 1,130,520 (New Position) | View |
| 2023-11-21 4:08 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | ROSENWALD LINDSAY A MD | 2,597,440 17.500% | 2,597,440 (New Position) | View |
| 2023-09-26 4:16 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,444,239 11.300% | 80,906 (+3.42%) | View |
| 2023-09-18 5:08 pm Purchase | 13D | AVENUE THERAPEUTICS INC. ATXI | Fortress Biotech Inc. FBIO | 1,049,056 12.100% | 1,049,056 (New Position) | View |
| 2023-07-06 4:44 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,363,333 13.600% | 81,406 (+3.57%) | View |
| 2023-04-19 4:24 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,281,927 17.500% | 78,214 (+3.55%) | View |
| 2023-02-14 5:01 pm Sale | 13G | FORTRESS BIOTECH INC FBIO | Nantahala Capital Management LLC | 7,968,056 7.300% | -1,117,949 (-12.30%) | View |
| 2023-02-14 4:35 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | KATZ DARYL | 6,052,975 4.760% | 445,604 (+7.95%) | View |
| 2023-02-09 11:19 am Sale | 13G | FORTRESS BIOTECH INC FBIO | VANGUARD GROUP INC | 5,104,407 4.700% | -585,867 (-10.30%) | View |
| 2023-01-13 4:13 pm Purchase | 13D | MUSTANG BIO INC. MBIO | Fortress Biotech Inc. FBIO | 22,880,620 20.700% | 22,880,620 (New Position) | View |